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optimal health care through the elicitation of physicians’ and
pharmacists’ preferences to health care, even in the particular
context of hemophilia management.
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OBJECTIVES: Inadequate treatment of haemophiliacs leads to
high rate of chronic arthropathy, high number of transfusion-
transmitted diseases and poor social integration. The objectives
of our study were to measure HRQOL and utilities in
haemophilia patients and to evaluate the inﬂuence of
haemophilia severity, patient’s age and socio-professional status
on HRQOL and utilities. METHODS: We used SF-36 and EQ-
5D questionnaires in 100 haemophilia patients with severe (66),
moderate (18) and mild form (16 cases), registered and treated
in Haemophilia Center Timisoara. Mean age of the patients was
23.14 years. We considered two age groups: 16–24 years (60
patients) and 25–34 years (40 patients). Seventeen of the
haemophiliacs were schoolboys, 13-university students, 19-
employees and 51 were handicapped with social support.
RESULTS: Compared with Romanian general population norms
(available only for SF-36 questionnaire) HRQOL is affected in
haemophilia patients in both age groups, although age was not
a strong predictor of HRQOL or utilities. Haemophilia severity
was found to have a strong inﬂuence on HRQOL and utilities.
Regarding the socio-professional status, handicapped with social
support had the lowest HRQOL scores and utilities values.
CONCLUSIONS: Our results conﬁrm the need to develop
special long-term national programs in order to improve
haemophilia treatment, to reduce the number and the severity of
complications, to offer a better social integration of the patients
and to improve their quality of life.
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OBJECTIVES: To establish which characteristics patients con-
sider important in prophylaxis, and if cost of treatment could
inﬂuence their preferences. METHODS: A focus group identi-
ﬁed ﬁve characteristics: type of product (plasma-derived vs.
recombinant), infusions frequency, hemorrhages frequency, pos-
sibility to do vigorous physical activities, possibility to do usual
activities. Patients gave their opinion rating each characteristic
from zero (not important) to 100 (very important). Scenarios
describing hypothetical treatment modalities were administered
to patients who were asked to chose one for each couple pre-
sented. The characteristic “cost”, expressed as increase in health
care taxes, was then added in each scenario and patients were
invited to make again their choices. RESULTS: Fifteen people,
13 adult patients and 2 parents, were enrolled. The characteris-
tic considered most important was “usual activities” (median =
95), followed by “hemorrhages frequency” (86), “infusions fre-
quency” (81), “type of product” (76), “vigorous physical activ-
ities” (69) and ﬁnally “cost” (50). Almost all patients did not
suggest other important characteristics. Eleven patients (73%)
changed at least one choice when “cost” was present. CON-
CLUSIONS: This pilot study allowed us to identify aspects con-
sidered by hemophilia patients as important in prophylaxis.
These results will help us to design a Conjoint Analysis aimed at
evaluating utilities and monetary value of these aspects.
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OBJECTIVES: We evaluated Health-Related Quality of Life
(HR-QoL) in hemophilia people with inhibitors and investigated
if QoL is associated to patients’ clinical status. METHODS: The
COCIS (Cost Of Care of Inhibitors) study was a longitudinal
study involving 52 hemophiliacs (median age 35, 15–64) with
inhibitors, 98% high responders, sequentially enrolled at 11
Italian Hemophilia Care Centers. Information on demographics,
clinical status, health-care resources consumption was prospec-
tively collected. QoL was investigated by means of the generic
instruments EQ-5D and SF-36. RESULTS: With the EQ-proﬁle
the majority of patients reported some/moderate problems 
in domains “pain/discomfort” (72%), “mobility” (66%) and
“usual activities” (54%). Around one third declared some/mod-
erate problems with “anxiety/depression” (34%) and “self-care”
(32%). No more than 6% of patients reported severe problems
in any of the domains. The EQ-Visual Analogue Scale (VAS),
measuring the global health state perception, was normally dis-
tributed, with a median value of 66 (30–95). The SF-Mental
Component Summary (MCS) had a median value of 52.8
(15.5–68.1), while the SF-Physical Component Summary (PCS)
had a median value of 35.2 (15.2–55.0). A strong association
was found between orthopedic status and global HR-QoL (EQ-
VAS, Pearson’s r = 0.56, p < 0.01). In particular, the physical
component of HR-QoL was the most inﬂuenced by the patients’
orthopedic status (Physical Component Summary, Pearson’s r =
-0.359, p < 0.01). Other clinical parameters, in particular
inhibitor titers and bleeding frequency, were not associated with
patients’ HR-QoL. CONCLUSIONS: Modern health care strate-
gies aimed at treating or, better, at preventing hemophilic
arthropathy should be considered to improve quality of life in
inhibitor patients.
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OBJECTIVES: The aim of this work is to evaluate inﬂuence of
clinical and socio-demographic characteristics on the strength of
preferences towards each characteristic. METHODS: We ana-
lyzed data originated by CONAN database from 178 patients.
Patients were asked to make choices between variables of
replacement therapy such as perceived viral safety, risk of
inhibitor development, infusion frequency on prophylaxis, phar-
maceutical dosage form, way of distribution and price.
RESULTS: The value of each characteristic was indicated by its
monetary value: the monetary value for perceived viral safety
was greater for moderate (2547€) compared to severe hemo-
